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We analysed data on 8987 larynx and 174060 lung cancer patients diagnosed between 1985 and 2004, of which 17.3% of larynx
and 35.5% of lung cancers were in females. The age-standardised rates for each cancer declined in both sexes, but since the 1990s,
the rates in females over 70 years of age have been diverging.
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It is informative to compare trends in the epidemiology of larynx
and lung cancer, as they share several characteristics. Both are
more common among males, predominately affect older adults,
and are strongly associated with tobacco smoking and socio-
economic deprivation (Thorne et al, 1997; Brewster and Møller,
2005; Wood et al, 2005; Groome et al, 2006; DAHNO, 2007; Quinn
et al, 2001a,b). In 1994, the majority of larynx cancer in England
and Wales was recorded as occurring in the area of the glottis,
followed by the supraglottis, with a small proportion in the
subglottis and laryngeal cartilages. A large proportion remained
unspecified (Quinn et al, 2001a).
Smoking, particularly of cigarettes, is a well-established risk
factor for both larynx and lung cancer (IARC, 1986, 2002). Alcohol
consumption is also independently associated with larynx cancer
(IARC, 1988; Altieri et al, 2002; Talamini et al, 2002; Bosetti
et al, 2002a; Vaezi et al, 2006), and the joint effect of smoking
and alcohol is approximately multiplicative (Tuyns et al, 1988;
Talamini et al, 2002; Altieri et al, 2005). Alcohol consumption is
not considered as a causal factor in lung cancer (IARC, 1988),
although a weak increase in risk has been observed in one meta-
analysis (Bagnardi et al, 2001).
Another risk factor for larynx cancer is gastro-oesophageal
reflux disease (GORD), especially in heavy smokers (Vaezi et al,
2006). Poor diet, human papillomaviruses (HPVs), and exposure to
asbestos and other occupational hazards have also been impli-
cated, but the evidence is less conclusive (Cattaruzza et al, 1996;
Quinn et al, 2001a; Bosetti et al, 2002b; Olshan, 2006). Although
smoking is the dominant risk factor for lung cancer, occupational
exposures to industrial carcinogens also increase the risk (Quinn
et al, 2001b; Wood et al, 2005).
In males over the age of 45 years, the risk of developing larynx
cancer is around five times higher than in females (DAHNO, 2007),
and consequently epidemiological studies can rarely include large
numbers of females. The Thames Cancer Registry covers an area
of south-east England, which by 2004 included a population of
14 million residents. The size of its database provided an
opportunity to compare trends in the incidence of larynx and
lung cancer in both sexes between 1985 and 2004.
MATERIALS AND METHODS
In the United Kingdom, cancer registries record the occurrence of
new cases of cancer in their residential populations. During the
study period, the Thames Cancer Registry covered a population
living in Essex, Hertfordshire, London, Kent, Surrey, and Sussex.
In this area, registration is initiated by pathology and clinical
information received from hospitals. Information about death is
provided by the National Health Service Central Register through
the Office for National Statistics. Trained data collection officers
seek further information from the medical records on demo-
graphic details, tumour characteristics including disease stage, and
treatment. Data are added to a central database, quality-assured,
and are updated continuously.
We extracted data on 8987 patients (7429 males and 1558
females) with larynx cancer (ICD-10 C32) and 174060 patients
(112333 males and 61727 females) with lung cancer (ICD-10 C33-
C34) diagnosed between 1985 and 2004 and resident in the area.
We aggregated data into the main morphology groups: adeno-
carcinoma, small cell carcinoma, squamous cell carcinoma, other,
and unspecified. For larynx cancer, we considered the anatomical
subgroups of glottis, supraglottis, laryngeal cartilage, and not
otherwise specified. We calculated directly age-standardised
incidence rates using the European standard population for the
four periods: 1985–1989, 1990–1994, 1995–1999, and 2000–2004
for males and females separately. We then calculated the average
annual percentage change in incidence per 5-year period of
diagnosis using weighted log-linear regression. We also calculated
truncated age-standardised rates for the age groups (in years):
0–49, 50–59, 60–69, 70–79, and 80 plus.
Received 13 August 2008; revised 21 October 2008; accepted 24
October 2008; published online 18 November 2008
*Correspondence: V Coupland; E-mail: victoria.coupland@kcl.ac.uk
British Journal of Cancer (2009) 100, 167–169
& 2009 Cancer Research UK All rights reserved 0007– 0920/09 $32.00
www.bjcancer.com
E
p
i
d
e
m
i
o
l
o
g
yRESULTS
Table 1 shows the smaller proportion of larynx (17.3%) and lung
cancer (35.5%) diagnoses in females. Most larynx cancers were
recorded as squamous cell carcinoma (83.3% in males and 77.2%
in females). This proportion was lower in lung cancer (27.8% in
males and 19.1% in females) where more were adenocarcinoma,
small cell carcinoma, and other specified morphologies. Approxi-
mately 47.1% of male and 50.2% of female lung cancer patients
had unspecified morphology. In larynx cancer, the glottis and
supraglottis were the two main sites making up over one-half of all
tumours. The proportion of females with glottis cancer was lower
(26.4%) than for males (42.4%), whereas cancer of the supraglottis
was more common in females (24.4%) than males (14.2%).
However, a large proportion of cancers in each sex had no
information on anatomical subsite (42.1% of males and 45.1%
of females).
Figure 1 shows the age-standardised and truncated age-
standardised incidence rates for larynx and lung cancer. In both
cancers, the rates were much lower in females than in males. The
greatest decline over time was in male lung cancer, with the
percentage change in incidence per 5-year period of diagnosis
being 15.6% compared with only 2.1% in females. The rates for
larynx cancer also declined in both sexes, with a percentage change
per 5-year period of diagnosis of 6.6% in males and 6.3% in
females. The truncated age-standardised incidence rates for both
larynx and lung cancer in men were highest in the over-70 age
groups, whereas in women, they were highest in the 70–79 age
group. The rates of female larynx and lung cancer in the over-70
age group diverged from the early 1990s, with rates in larynx
cancer declining and those in lung cancer increasing. In larynx
cancer, rates in the female 70–79 age group declined faster
than in the 80 plus group, whereas in lung cancer, the rate in the
female 80 plus group increased faster than in the 70–79 age
group. Age-standardised rates by birth cohort showed stronger
trends in lung cancer compared with larynx cancer between 1900
and 1950 (data not shown). In male lung cancer, rates declined in
successive generations and female rates increased, whereas in both
sexes, larynx cancer rates appeared fairly stable across birth
cohorts.
Table 1 Clinical characteristics of patients diagnosed with larynx and
lung cancer in south-east England, 1985–2004
Males Females
Larynx cancer (ICD10 C32) N (%) N (%)
All cases 7429 (82.7) 1558 (17.3)
Morphology
Adenocarcinoma 27 (0.4) 18 (1.2)
Small cell carcinoma 11 (0.1) 12 (0.8)
Squamous cell carcinoma 6190 (83.3) 1202 (77.2)
Other specified morphologies 73 (1.0) 16 (1.0)
Unspecified morphologies 1128 (15.2) 310 (19.9)
Anatomical subsite
Glottis 3149 (42.4) 411 (26.4)
Supraglottis 1054 (14.2) 380 (24.4)
Subglottis 76 (1.0) 55 (3.5)
Laryngeal cartilage 25 (0.3) 10 (0.6)
Larynx (not otherwise specified) 3125 (42.1) 702 (45.1)
Lung cancer (ICD10 C33-C34)
All cases 112333 (64.5) 61727 (35.5)
Morphology
Adenocarcinoma 11889 (10.6) 8861 (14.4)
Small cell carcinoma 11822 (10.5) 7702 (12.5)
Squamous cell carcinoma 31229 (27.8) 11765 (19.1)
Other specified morphologies 4479 (4.0) 2441 (4.0)
Unspecified morphologies 52914 (47.1) 30958 (50.2)
0
5
10
15
20
25
30
35
1985–1989 1990–1994 1995–1999 2000–2004 1985–1989 1990–1994 1995–1999 2000–2004
Period of diagnosis
1985–1989 1990–1994 1995–1999 2000–2004
Period of diagnosis
T
r
u
n
c
a
t
e
d
 
a
g
e
-
s
t
a
n
d
a
r
d
i
s
e
d
 
r
a
t
e
80+
70–79
60–69
50–59
0–49
All ages
80+
70–79
60–69
50–59
0–49
All ages
80+
70–79
60–69
50–59
0–49
All ages
80+
70–79
60–69
50–59
0–49
All ages
0
1
2
3
4
5
6
T
r
u
n
c
a
t
e
d
 
a
g
e
-
s
t
a
n
d
a
r
d
i
s
e
d
 
r
a
t
e
0
100
200
300
400
500
600
700
800
900
Period of diagnosis
1985–1989 1990–1994 1995–1999 2000–2004
Period of diagnosis
T
r
u
n
c
a
t
e
d
 
a
g
e
-
s
t
a
n
d
a
r
d
i
s
e
d
 
r
a
t
e
0
50
100
150
200
250
T
r
u
n
c
a
t
e
d
 
a
g
e
-
s
t
a
n
d
a
r
d
i
s
e
d
 
r
a
t
e
Figure 1 Trends in truncated age-standardised rates for larynx cancer and lung cancer in male and female residents of south-east England, 1985–2004.
(A) Larynx cancer in males. (B) Larynx cancer in females. (C) Lung cancer in males. (D) Lung cancer in females.
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This study of the epidemiology of larynx and lung cancer in south-
east England found that both cancers affected predominantly
males aged over 70 years, and that females represented 17.3% of
larynx and 35.5% of lung cancer diagnoses. The age-standardised
incidence rates for each cancer declined in both sexes between
1985 and 2004, but to a greater extent for lung cancer in males. The
incidence of larynx and lung cancer declined in males in all age
groups over 60 years, but the incidence of these two cancers in
females aged over 70 years diverged from the early 1990s. Whereas
the incidence of lung cancer increased in the 70–79 and 80 plus
age groups, the rates for larynx cancer declined in these groups.
The main limitation of our study is that it was based on cancer
registration data, which relies on the information available in
medical records. Data on disease morphology were incomplete,
a large proportion of larynx cancer cases had no information
on anatomical subsite, and information on individual risk
factors such as smoking and alcohol consumption is not available.
Although data from a 20-year period for approximately one-
quarter of the English population provided sufficient numbers of
female patients with larynx cancer to allow more detailed
description of its epidemiology than previously, the incidence
rates were still based on relatively small numbers.
Some findings of our study, such as the predominance of male
patients, and the decline in the age-standardised incidence rates of
both cancers up until 2004 are similar to those reported previously
by national studies (Quinn et al, 2001a, 2001b; Brewster and
Møller, 2005; Wood et al, 2005; DAHNO, 2007). The new finding
of diverging trends for the two cancers in females over 70, with
larynx cancer rates declining, whereas the lung cancer rates increase
is surprising. This could reflect past differences in smoking
behaviours between males and females, or possibly a decline in the
effect of additional risk factors for larynx cancer, including alcohol
consumption, GORD, poor diet, and HPV infection (Cattaruzza
et al, 1996; Quinn et al, 2001a; Bosetti et al, 2002b; Olshan, 2006;
Vaezi et al, 2006). A study of 33 European countries between 1980
and 2001 found stronger similarities in mortality trends between
larynx and other alcohol-related cancers than between larynx and
lung cancer, suggesting that alcohol consumption is most likely to
be important (Bosetti et al, 2006).
The large proportion of larynx cancer assigned to unknown
anatomical subsite emphasises the need for better recording of this
information after surgery and its transfer to the cancer registry to
enable comparative analyses across the regions and over time
(Department of Health, 2007). Several findings of this study could
be explored using larger data sets. First, our finding of a decline in
the age-standardised rate of larynx cancer in males and females in
south-east England should be compared with other regions of the
United Kingdom and other countries. Second, investigation could
compare the trends in different age groups between larynx and
other alcohol-related cancers. Third, the higher proportion of
supraglottis larynx cancer in females may be an artefact of
incomplete data, but could be explored in other regions in case
there may be a higher risk for female disease at this site. Finally,
the decline in the incidence of both cancers over the 20 years is
a positive finding. However, the continuing increase of lung
cancer among older females emphasises the need to continue to
develop smoking cessation programmes to reach this group, as
there is good evidence that individuals who give up smoking
in middle age can avoid the majority of their subsequent risk
(Peto et al, 2000).
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